TCBP
Price
$0.33
Change
-$0.02 (-5.71%)
Updated
Dec 8, 6:59 PM EST
XBIO
Price
$3.92
Change
-$0.25 (-6.00%)
Updated
Dec 8, 6:59 PM EST
Ad is loading...

TCBP vs XBIO ᐉ Comparison: Which is Better to Invest?

Header iconTCBP vs XBIO Comparison
Open Charts TCBP vs XBIOBanner chart's image
TC BioPharm (Holdings)
Price$0.33
Change-$0.02 (-5.71%)
Volume$354.95K
CapitalizationN/A
Xenetic Biosciences
Price$3.92
Change-$0.25 (-6.00%)
Volume$1.74K
CapitalizationN/A
View a ticker or compare two or three
TCBP vs XBIO Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
TCBP vs. XBIO commentary
Dec 11, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TCBP is a Hold and XBIO is a Hold.

COMPARISON
Comparison
Dec 11, 2023
Stock price -- (TCBP: $0.32 vs. XBIO: $3.94)
Brand notoriety: TCBP and XBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TCBP: 60% vs. XBIO: 71%
Market capitalization -- TCBP: $3.93M vs. XBIO: $4.78M
TCBP [@Biotechnology] is valued at $3.93M. XBIO’s [@Biotechnology] market capitalization is $4.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TCBP’s FA Score shows that 1 FA rating(s) are green whileXBIO’s FA Score has 1 green FA rating(s).

  • TCBP’s FA Score: 1 green, 4 red.
  • XBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, XBIO is a better buy in the long-term than TCBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TCBP’s TA Score shows that 3 TA indicator(s) are bullish.

  • TCBP’s TA Score: 3 bullish, 7 bearish.

Price Growth

TCBP (@Biotechnology) experienced а -18.71% price change this week, while XBIO (@Biotechnology) price change was +11.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10161.68%. For the same industry, the average monthly price growth was +8.48%, and the average quarterly price growth was +27.10%.

Reported Earning Dates

XBIO is expected to report earnings on Aug 11, 2023.

Industries' Descriptions

@Biotechnology (+10161.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for TCBP with price predictions.
OPEN
A.I.dvisor published
a Summary for XBIO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
XBIO($4.78M) has a higher market cap than TCBP($3.93M). XBIO YTD gains are higher at: 38.334 vs. TCBP (-91.660). XBIO has higher annual earnings (EBITDA): -4.82M vs. TCBP (-10.52M). XBIO has more cash in the bank: 9.78M vs. TCBP (1.57M). XBIO has less debt than TCBP: XBIO (153K) vs TCBP (9.71M). XBIO has higher revenues than TCBP: XBIO (2.36M) vs TCBP (1.98M).
TCBPXBIOTCBP / XBIO
Capitalization3.93M4.78M82%
EBITDA-10.52M-4.82M218%
Gain YTD-91.66038.334-239%
P/E RatioN/AN/A-
Revenue1.98M2.36M84%
Total Cash1.57M9.78M16%
Total Debt9.71M153K6,346%
FUNDAMENTALS RATINGS
XBIO: Fundamental Ratings
XBIO
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TCBP
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 26 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AFRM42.072.66
+6.75%
Affirm Holdings
MDXH3.390.11
+3.35%
MDxHealth SA
WTO0.240.01
+2.52%
UTime Limited
MTX63.84-0.15
-0.23%
Minerals Technologies
JANX9.01-0.41
-4.35%
Janux Therapeutics